New Funding Opportunity: Research Design Phase for major Cardiometabolic Obesity Prevention Study (COPS)

The Scottish Government Chief Scientist Office (CSO), in collaboration with the Office for Life Sciences (OLS), is inviting applications for a new funding opportunity to support the design of a high-impact prospective clinical trial to be delivered in Scotland. This will be a key component of the UK Obesity Healthcare Goals programme, and builds on Scotland’s reputation for conducting world-class, real-world research that shapes global clinical guidelines. The wider COPS Programme aims to deliver a robust, impactful, and innovative clinical trial, investigating the effects of weight loss medications on obesity-related conditions, with the goal of transforming care pathways and improving long-term health outcomes.

As an initial phase for this ambitious programme, we are inviting submissions for a Research Design Study -this is a foundational step in shaping a bold, innovative approach to tackling obesity through cutting-edge research, data infrastructure, and cross-sector collaboration. Up to £650,000 is available for the 12-month research design phase, with the opportunity for successful applicants to secure additional funding to deliver the full clinical trial

For further details, including how to submit an Expression of Interest, please go to the CSO/OLS COPS Grant page.